Gene therapy has proven to be a promising treatment for rare diseases like muscular dystrophy. As these life-saving treatments enter the market, however, their high costs pose affordability challenges for individuals living with rare diseases. In our upcoming virtual conversation, “5 Slides: Gene therapy and the promise for rare disease,” we will host … Read more
The question of increasing affordable access to care has risen to the forefront of health policy conversations in the wake of COVID-19 — a shift from previously cost-focused models. In the world of pharmacy, health leaders are engaging in conversations about navigating cost pressures as Virginia begins to, hopefully, return to normal. State of Reform … Read more
Gene therapy represents a new generation of medicine that shows great promise in the fight against rare genetic diseases. The potential long-term transformative benefits could reduce, or even eliminate the ongoing costs of supporting patients and managing diseases. State of Reform is looking forward to exploring this issue in depth at our upcoming “5 Slides: Gene … Read more